Diagnostic value of triglyceride and cystatin C ratio in diabetic kidney disease: a retrospective and prospective cohort study based on renal biopsy

被引:11
|
作者
Wei, Jing [1 ]
Wang, Bo [2 ]
Shen, Feng-jie [1 ]
Zhang, Ting-ting [1 ]
Duan, Zan [3 ]
Zhou, Dong-mei [4 ]
机构
[1] Xuzhou Med Univ, Dept Endocrinol, Affiliated Hosp, Xuzhou 221000, Jiangsu, Peoples R China
[2] First Peoples Hosp Xuzhou, Dept Endocrinol, Xuzhou 221000, Jiangsu, Peoples R China
[3] Xuzhou Canc Hosp, Dept Pathol, Xuzhou 221000, Jiangsu, Peoples R China
[4] Xuzhou Med Univ, Affiliated Hosp, Dept Rheumatol & Immunol, Xuzhou 221000, Jiangsu, Peoples R China
关键词
Triglyceride and cystatin C ratio; Diabetic kidney disease; Diagnosis; Renal biopsy; MELLITUS; METAANALYSIS; NEPHROPATHY;
D O I
10.1186/s12882-022-02888-3
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background Currently, there is a lack of clinical indicators that can accurately distinguish diabetic kidney disease (DKD) from non-diabetic kidney disease (NDKD) in type 2 diabetes. The purpose of this study was to investigate the diagnostic value of triglyceride and cystatin C (TG/ Cys-C) ratio in DKD. Nowadays, there are few studies on the differential diagnosis of TG/ Cys-C ratio between DKD and NDKD. Methods The clinical data of patients with type 2 diabetes complicated with proteinuria who underwent renal biopsy from January 2013 to September 2019 in 2 hospitals in Xuzhou were retrospectively collected. According to the pathological classification of kidney, 25 patients in group DKD and 34 patients in non-diabetic kidney disease (NDKD) group were divided into two groups. The admission information and blood biochemical indexes of all patients with renal biopsy were collected, and the TG / Cys-C ratio was calculated. Logistic regression analysis was used to analyze the related factors of DKD in patients with type 2 diabetes and proteinuria. Receiver operating characteristic (ROC) curve was used to evaluate the diagnostic value of TG/Cys-C ratio for DKD in patients with type 2 diabetes and proteinuria. Another 37 patients with type 2 diabetes complicated by proteinuria who were treated in the Department of Nephrology, four hospitals in Xuzhou from October 2019 to October 2021 were selected as the research objects. The TG/Cys-C value cut-off value selected in the retrospective study was selected as the boundary point and divided into two groups according to the values of greater than or equal to the tangent point and less than the tangential point. Serum triglyceride and cystatin C levels were measured and TG / Cys-C ratio was calculated. All patients underwent ultrasound-guided fine-needle renal biopsy. The positive rates of DKD diagnosis in the two groups were compared to verify the predictive value of TG / Cys-C ratio in the diagnosis of DKD. Results Retrospective study showed that compared with group NDKD, the DKD group had higher systolic blood pressure, higher cystatin C and creatinine, more diabetic retinopathy, longer duration of diabetes, lower hemoglobin concentration, lower glomerular filtration rate, lower cholesterol, lower triglyceride and lower TG/ Cys-C ratio (P < 0.05).Multivariate Logistic regression analysis showed that TG/Cys-C ratio (OR = 0.429, P = 0.009) was a protective factor for DKD in patients with type 2 diabetes and proteinuria. Diabetic retinopathy (OR = 7.054, P = 0.021) and systolic blood pressure (OR = 1.041, P = 0.047) were independent risk factors for DKD in patients with type 2 diabetes complicated with proteinuria. ROC curve showed that the area under the curve predicted by TG/Cys-C ratio for the diagnosis of DKD was 0.816, the sensitivity was 84%, and the specificity was 67.6%. The tangent value of TG / Cys-C ratio is 2.43. Prospective studies showed that in 37 patients with type 2 diabetes and proteinuria, 29 patients had a TG/Cys-C ratio of less than 2.43. The TG/Cys-C ratio of 8 patients was more than 2.43. Ultrasound guided fine needle aspiration biopsy revealed that 22 of the 29 patients had pathological diagnosis of DKD, sensitivity 91.67%, specificity 46.15%, positive predictive value 75.80%, and negative predictive value 75%. Conclusion In type 2 diabetic patients with proteinuria, the ratio of TG/Cys-C has certain predictive value for the diagnosis of DKD.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Diagnostic value of triglyceride and cystatin C ratio in diabetic kidney disease: a retrospective and prospective cohort study based on renal biopsy
    Jing Wei
    Bo Wang
    Feng-jie Shen
    Ting-ting Zhang
    Zan Duan
    Dong-mei Zhou
    BMC Nephrology, 23
  • [2] Prognostic Value of Hemoglobin Concentration on Renal Outcomes with Diabetic Kidney Disease: A Retrospective Cohort Study
    Chen, Xiaojie
    Xie, Jianteng
    Zhang, Yifan
    Zhang, Shaogui
    Li, Sheng
    Lu, Min
    Liu, Danfeng
    He, Weiting
    Yau, Hokhim
    Jia, Runli
    Zhu, Yaxi
    Wang, Wenjian
    DIABETES METABOLIC SYNDROME AND OBESITY, 2024, 17 : 1367 - 1381
  • [3] Serum hemoglobin concentration and risk of renal function decline in early stages of diabetic kidney disease: a nationwide, biopsy-based cohort study
    Yamanouchi, Masayuki
    Furuichi, Kengo
    Shimizu, Miho
    Toyama, Tadashi
    Yamamura, Yuta
    Oshima, Megumi
    Kitajima, Shinji
    Hara, Akinori
    Iwata, Yasunori
    Sakai, Norihiko
    Oba, Yuki
    Matsuoka, Shusaku
    Ikuma, Daisuke
    Mizuno, Hiroki
    Suwabe, Tatsuya
    Hoshino, Junichi
    Sawa, Naoki
    Yuzawa, Yukio
    Kitamura, Hiroshi
    Suzuki, Yoshiki
    Sato, Hiroshi
    Uesugi, Noriko
    Ueda, Yoshihiko
    Nishi, Shinichi
    Yokoyama, Hitoshi
    Nishino, Tomoya
    Samejima, Kenichi
    Kohagura, Kentaro
    Shibagaki, Yugo
    Makino, Hirofumi
    Matsuo, Seiichi
    Ubara, Yoshifumi
    Wada, Takashi
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 (03) : 489 - 497
  • [4] Huobahuagen tablet improves renal function in diabetic kidney disease: a real-world retrospective cohort study
    Tan, Ying
    Li, Ruihan
    Zhou, Peipei
    Li, Nan
    Xu, Weilong
    Zhou, Xiqiao
    Yan, Qianhua
    Yu, Jiangyi
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [5] Serum Cystatin C as an Early Diagnostic Biomarker of Diabetic Kidney Disease in Type 2 Diabetic Patients
    Qamar, Ayesha
    Hayat, Asma
    Ahmad, Tariq Mahmood
    Khan, Alamgir
    ul Hasnat, Mohammad Najam
    Tahir, Sufyan
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2018, 28 (04): : 288 - 291
  • [6] Burden of Undiagnosed Type 2 Diabetes in Diabetic Kidney Disease: A Japanese Retrospective Cohort Study
    Tanabe, Hayato
    Saito, Haruka
    Machii, Noritaka
    Kudo, Akihiro
    Tanaka, Kenichi
    Asahi, Koichi
    Kazama, Junichiro James
    Shimabukuro, Michio
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (07) : 1 - 11
  • [7] The modern spectrum of biopsy proven renal disease in Chinese diabetic patients-a retrospective descriptive study
    Liu, Diankun
    Huang, Ting
    Chen, Nan
    Xu, Gang
    Zhang, Ping
    Luo, Yang
    Wang, Yongping
    Lu, Tao
    Wang, Long
    Xiong, Mengqi
    Geng, Jian
    Nie, Sheng
    PEERJ, 2018, 6
  • [8] Requirement for cystatin C testing in chronic kidney disease: a retrospective population-based study
    Lasserson, Daniel S.
    Shine, Brian
    O'Callaghan, Christopher A.
    James, Tim
    BRITISH JOURNAL OF GENERAL PRACTICE, 2017, 67 (663) : E732 - E735
  • [9] Neutrophil/Lymphocyte Ratio and All-Cause Mortality in Diabetic Kidney Disease: A Retrospective Cohort Study
    Bai, Yihua
    Huang, Lilan
    Li, Yanqin
    Zhou, Shiyu
    Li, Luohua
    Jiang, Hongying
    Nie, Sheng
    Feng, Zhijian
    Su, Licong
    JOURNAL OF INFLAMMATION RESEARCH, 2024, 17 : 10739 - 10753
  • [10] The role of kidney biopsy in deciphering diabetic versus non-diabetic origin of kidney disease among patients with type 2 diabetes mellitus and nephrotic range proteinuria: A retrospective study
    Kardalas, Efstratios
    Paikopoulou, Aggeliki
    Vassiliadi, Dimitra A.
    Kounatidis, Dimitris
    Vallianou, Natalia G.
    Vourlakou, Christine
    Karampela, Irene
    Dalamaga, Maria
    Tzanela, Marinella
    Stratigou, Theodora
    METABOLISM OPEN, 2024, 23